Literature DB >> 11995808

Ocular immune privilege and CD1d-reactive natural killer T cells.

Koh-Hei Sonoda1, Joan Stein-Streilein.   

Abstract

PURPOSE: Immune privilege in the eye is, in part, associated with the development of an antigen-specific systemic tolerance termed anterior chamber-associated immune deviation (ACAID). Natural killer T (NKT) cells express T-cell receptor and natural killer (NK) markers and are classified as innate immune cells partly because they produce cytokines within minutes of signals. The aim of this study was to elucidate the role of murine NKT cells in the induction of T regulatory cells in anterior chamber-associated immune deviation.
METHODS: Anterior chamber-associated immune deviation T regulatory cell generation ability was examined in the following NKT cell-deficient mice: SJL mice, CDld or Jalpha281 knockout (KO) mice on C57BL/6 (B6) background, and NKT cell-depleted mice. To detect T regulatory cells, splenic T cells were harvested 7 days after anterior chamber inoculation of ovalbumin (50 microg/2 microL in Hanks balanced salt solution [HBSS]), mixed with ovalbumin-primed T cells (effector) and ovalbumin-pulsed antigen-presenting cells (stimulator), and then cotransferred into the ear pinnae of a syngeneic naive mouse (local adoptive transfer assay). Ear swelling was measured 24 hours later.
RESULTS: Anterior chamber-inoculated B6 mice developed T regulatory cells, but all natural killer T cell-deficient mice did not generate T regulatory cells unless they were reconstituted with natural killer T cells. We also found that the number of splenic natural killer T cells were increased in anterior chamber-inoculated B6 mice and those natural killer T cells produced IL-10.
CONCLUSIONS: CD1d-reactive natural killer T cells are essential for the induction of T regulatory cells in anterior chamber-associated immune deviation through their IL-10 production and are involved in the maintenance of immune privilege of the eye.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11995808     DOI: 10.1097/00003226-200203001-00008

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

Review 2.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats.

Authors:  Y Jie; Z Pan; Y Chen; Y Wei; W Zhang; Y Wu; H Peng; L Xu
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 4.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

5.  Outcomes of ocular evisceration and enucleation in the British Armed Forces from Iraq and Afghanistan.

Authors:  Christopher J Holmes; Anthony McLaughlin; Tahir Farooq; John Awad; Aidan Murray; Robert Scott
Journal:  Eye (Lond)       Date:  2019-06-05       Impact factor: 3.775

Review 6.  Natural killer cells in rejection and tolerance of solid organ allografts.

Authors:  Gilles Benichou; Yohei Yamada; Akihiro Aoyama; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

7.  Ocular immune privilege.

Authors:  A W Taylor
Journal:  Eye (Lond)       Date:  2009-01-09       Impact factor: 3.775

Review 8.  Ocular Immune Privilege and Transplantation.

Authors:  Andrew W Taylor
Journal:  Front Immunol       Date:  2016-02-08       Impact factor: 7.561

9.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.

Authors:  S-M Hsu; R Mathew; A W Taylor; J Stein-Streilein
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.